Reproductive and Genetic Health (RGH) Portfolio: Tony Gordon | Illumina Video

March 3, 2015

Tony Gordon, Genesis Genomics Managing Director (US) and Lab Director (UK) discusses how the Illumina portfolio empowers reproductive health labs with its ability to run both pre-and postnatal tests on the same Illumina equipment. Learn more about how next-generation sequencing (NGS) is advancing reproductive genetic health.

Share this article on